Internal Medicine, Pulmonary Disease · Seattle, WA
NPI
1457436289
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
University of Washington Medical Ctr, 1959 NE Pacific St
Seattle, WA, 98195
Phone (206) 598-4615
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,551
98 services
Medicare patients, 2024
38
Average age 67
Drug cost, 2024
$3.8M
505 prescriptions
Company payments, 2025
$563
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher H Goss was code 99215 (office e&m - established), 47 times for 25 patients. In total Christopher H Goss billed 98 services in 9 codes, and Medicare paid $8,551.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 47 | 25 | $118.67 | $5,578 |
| 99214 Office E&M - Established | Facility | 19 | 13 | $77.72 | $1,477 |
By year: 2022 $14K for 148 services; 2023 $10K for 103 services; 2024 $8,551 for 98 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher H Goss prescribed most often to Medicare patients was Trikafta (Elexacaftor/Tezacaftor/Ivacaft), with 124 prescriptions and refills. In total Christopher H Goss wrote 505 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 124 | 124 | 16 | $3.3M |
| Azithromycin Generic | 46 | 88 | 12 | $335 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 37 | 56 | 11 | $5,345 |
| Dulera Mometasone/Formoterol | 21 | 28 | Under 11 | $5,620 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 20 | 20 | Under 11 | $1,760 |
| Fluticasone Propionate Generic | 19 | 31 | Under 11 | $139 |
| Zenpep Lipase/Protease/Amylase | 18 | 30 | Under 11 | $186K |
| Spiriva Handihaler Tiotropium Bromide | 14 | 24 | Under 11 | $12K |
| Celecoxib Generic | 12 | 12 | Under 11 | $1,005 |
| Atrovent Hfa Ipratropium Bromide | 12 | 12 | Under 11 | $27.48 |
| Prednisone Generic | 11 | 11 | Under 11 | $33.11 |
| Tobi Podhaler Tobramycin | 11 | 14 | Under 11 | $135K |
Brand drugs: 276 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher H Goss $563 ($563 in general payments such as food, travel and fees) from 3 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $563.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $563 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.